Daniel L. Rathbone

1.1k total citations
48 papers, 847 citations indexed

About

Daniel L. Rathbone is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Daniel L. Rathbone has authored 48 papers receiving a total of 847 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Organic Chemistry, 16 papers in Molecular Biology and 9 papers in Infectious Diseases. Recurrent topics in Daniel L. Rathbone's work include Synthesis and biological activity (8 papers), Blood properties and coagulation (6 papers) and Analytical chemistry methods development (6 papers). Daniel L. Rathbone is often cited by papers focused on Synthesis and biological activity (8 papers), Blood properties and coagulation (6 papers) and Analytical chemistry methods development (6 papers). Daniel L. Rathbone collaborates with scholars based in United Kingdom, New Zealand and United States. Daniel L. Rathbone's co-authors include David C. Billington, Martin Griffin, David H. G. Crout, Russell Collighan, Julie Simpson, Peter A. Lambert, Debbie L. Hay, David R. Poyner, Zejing Wang and James Barwell and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Advanced Drug Delivery Reviews.

In The Last Decade

Daniel L. Rathbone

48 papers receiving 825 citations

Peers

Daniel L. Rathbone

PRM

ONCOL

Anders Buur Denmark

Dimitra Benaki Greece

I Hayakawa Japan

Doo-Man Oh United States

Hanna Kumpulainen Finland

Robert A. Carr United States

Tae‐Sung Koo South Korea

Kuntebommanahalli N. Thimmaiah India

Mohammad Abdel‐Halim Egypt

Mu Yuan China

Anders Buur Denmark

Daniel L. Rathbone

179 ×0.7

286 ×1.2

51 ×0.3

PRM

46 ×0.4

224 ×2.0

ONCOL

Citations per year, relative to Daniel L. Rathbone Daniel L. Rathbone (= 1×) peers Anders Buur

Countries citing papers authored by Daniel L. Rathbone

Since Specialization

Citations

This map shows the geographic impact of Daniel L. Rathbone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel L. Rathbone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel L. Rathbone more than expected).

Fields of papers citing papers by Daniel L. Rathbone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel L. Rathbone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel L. Rathbone. The network helps show where Daniel L. Rathbone may publish in the future.

Co-authorship network of co-authors of Daniel L. Rathbone

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel L. Rathbone. A scholar is included among the top collaborators of Daniel L. Rathbone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel L. Rathbone. Daniel L. Rathbone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rathbone, Daniel L., et al.. (2023). A modified bonded model approach for molecular dynamics simulations of New Delhi Metallo-β-lactamase. Journal of Molecular Graphics and Modelling. 121. 108431–108431. 4 indexed citations

Lopeman, Rose C., James Harrison, Daniel L. Rathbone, et al.. (2020). Effect of Amoxicillin in combination with Imipenem-Relebactam against Mycobacterium abscessus. Scientific Reports. 10(1). 928–928. 43 indexed citations

Lopeman, Rose C., James Harrison, Daniel L. Rathbone, et al.. (2020). Author Correction: Effect of Amoxicillin in combination with Imipenem-Relebactam against Mycobacterium abscessus. Scientific Reports. 10(1). 4540–4540. 2 indexed citations

Rathbone, Daniel L., et al.. (2017). Reaction profiling of a set of acrylamide-based human tissue transglutaminase inhibitors. Journal of Molecular Graphics and Modelling. 79. 157–165. 5 indexed citations

Wang, Zejing, et al.. (2015). Development of Potent and Selective Tissue Transglutaminase Inhibitors: Their Effect on TG2 Function and Application in Pathological Conditions. Chemistry & Biology. 22(10). 1347–1361. 45 indexed citations

Collighan, Russell, et al.. (2013). Imidazolium-based warheads strongly influence activity of water-soluble peptidic transglutaminase inhibitors. European Journal of Medicinal Chemistry. 66. 526–530. 19 indexed citations

Collighan, Russell, Yvonne Perrie, Peter A. Lambert, et al.. (2012). Indwelling catheters and medical implants with FXIIIa inhibitors: A novel approach to the treatment of catheter and medical device-related infections. European Journal of Pharmaceutics and Biopharmaceutics. 83(1). 106–113. 7 indexed citations

Wang, Zejing, Russell Collighan, Kamila M Pytel, et al.. (2012). Characterization of Heparin-binding Site of Tissue Transglutaminase. Journal of Biological Chemistry. 287(16). 13063–13083. 58 indexed citations

Griffin, Martin, Russell Collighan, Robert E. Saint, et al.. (2008). Synthesis of potent water-soluble tissue transglutaminase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(20). 5559–5562. 63 indexed citations

10.

Costello, Cait M., T.J. Karpanen, Peter A. Lambert, et al.. (2008). Thiosemicarbazones active against Clostridium difficile. Bioorganic & Medicinal Chemistry Letters. 18(5). 1708–1711. 19 indexed citations

11.

Rathbone, Daniel L.. (2005). Molecularly imprinted polymers in the drug discovery process. Advanced Drug Delivery Reviews. 57(12). 1854–1874. 42 indexed citations

12.

Coleman, Michael D., et al.. (2004). Effects of glutathione, N-acetyl-cysteine, α-lipoic acid and dihydrolipoic acid on the cytotoxicity of a 2-pyridylcarboxamidrazone antimycobacterial agent in human mononuclear leucocytes in vitro. Environmental Toxicology and Pharmacology. 17(3). 143–148. 3 indexed citations

13.

Coleman, Michael D., et al.. (2003). The use of computational QSAR analysis in the toxicological evaluation of a series of 2-pyridylcarboxamidrazone candidate anti-tuberculosis compounds. Environmental Toxicology and Pharmacology. 14(1-2). 33–42. 9 indexed citations

14.

Simpson, Julie, Rebecca Forrester, Michael J. Tisdale, David C. Billington, & Daniel L. Rathbone. (2003). Effect of catechol derivatives on cell growth and lipoxygenase activity. Bioorganic & Medicinal Chemistry Letters. 13(15). 2435–2439. 12 indexed citations

15.

Gokhale, Nikhil H., Subhash Padhyé, David C. Billington, et al.. (2003). Synthesis and characterization of copper(II) complexes of pyridine-2-carboxamidrazones as potent antimalarial agents. Inorganica Chimica Acta. 349. 23–29. 27 indexed citations

16.

Sandbhor, Uday, Subhash Padhyé, David C. Billington, et al.. (2002). Metal complexes of carboxamidrazone analogs as antitubercular agents. Journal of Inorganic Biochemistry. 90(3-4). 127–136. 38 indexed citations

17.

Coleman, Michael D., et al.. (2001). Preliminary in vitro toxicological evaluation of a series of 2-pyridylcarboxamidrazone candidate anti-tuberculosis compounds III. Environmental Toxicology and Pharmacology. 9(3). 99–102. 4 indexed citations

18.

Billington, David C., et al.. (2000). A new amidrazone derivative with antimycobacterial activity. Acta Crystallographica Section C Crystal Structure Communications. 56(5). e211–e212. 5 indexed citations

19.

Coleman, Michael D., et al.. (1999). Preliminary in vitro toxicological evaluation of a series of 2-pyridylcarboxamidrazone candidate anti-tuberculosis compounds. Environmental Toxicology and Pharmacology. 7(1). 59–65. 6 indexed citations

20.

Jones, J. H., Daniel L. Rathbone, & Peter B. Wyatt. (1987). The Regiospecific Alkylation of Histidine Side Chains. Synthesis. 1987(12). 1110–1113. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact